A Temple News article highlighted the development of the BASHIR™ Endovascular Catheter (THROMBOLEX, Inc.), invented by Riyaz Bashir, MD, FACC, Director of Vascular and Endovascular Medicine at Temple University Hospital (TUH) and Professor of Medicine at the Lewis Katz School of Medicine at Temple University, and developed by Thrombolex Inc. The article also included perspective from Paul Forfia, MD, Co-Director of the Pulmonary Hypertension, Right Heart Failure & Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Program at TUH; and Anjali Vaidya, MD, FACC, FASE, FACP, Co-Director of the Pulmonary Hypertension, Right Heart Failure & CTEPH Program at TUH.
Weather Alert: A major winter storm is likely to impact the Philadelphia region this weekend into Monday. Temple Health remains open, though some appointments or services may be adjusted. Patients will be contacted directly if their visit is affected. Please check TempleHealth.org for updates and monitor myTempleHealth for changes to scheduled appointments.
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH